A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial (COG ACNS0331)
Brain and Nervous System | Central Nervous System Tumor
What is the purpose of this trial?
A Study Evaluating Limited Target Volume Boost Irradiation & Reduced Dose Craniospinal Radiotherapy (18.00Gy ) & Chemotherapy in Children w/Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Blind Trial
- 3 Years - 21 Years
Click here for detailed information about who can participate in this trial.
- Children's Oncology Group (The)
National Cancer Institute (NCI)
- Last Updated:
- Study HIC#: